Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
499.40    -0.60 (-0.12%)
Bid:
500.00
Ask:
501.00
Spread: 1.00 (0.20%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Director/PDMR Shareholding

16 Dec 2025 07:00

RNS Number : 6641L
Chemring Group PLC
16 December 2025
 

16 December 2025

 

Chemring Group PLC

 

PDMR share dealings

 

 

Chemring Group PLC ("Chemring" or the "Company") announces that on 15 December 2025

an award of 131,137 ordinary 1p shares in the capital of the Company previously granted to Sarah Ellard, a director of the Company, on 14 December 2022 under the Chemring Group Performance Share Plan vested in part to the extent of 65,568 ordinary 1p shares. The balance of the award has lapsed. Further details on the basis for vesting of the award were disclosed in the Company's 2025 Annual Report. Following the vesting, 30,971 ordinary 1p shares were sold by the Company on behalf of Mrs Ellard on 15 December 2025 to cover tax and national insurance liabilities arising on vesting.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 1p shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Vesting of performance share plan award

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil

 

65,568

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

15 December 2025

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 1p shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Sale of ordinary 1p shares to meet tax and national insurance liabilities following vesting of performance share plan award

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

481p

 

30,971

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

15 December 2025

f)

 

Place of the transaction

 

 

XLON - London Stock Exchange

 

 

For further information:

 

Chemring Group PLC

Sarah Ellard

Group Legal Director & Company Secretary

+44 (0)7710 553757

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFIFFSLELIE
Date   Source Headline
1st May 201810:26 amRNSTotal Voting Rights
1st May 20187:00 amRNSDirectorate Change
27th Apr 20183:41 pmRNSHolding(s) in Company
23rd Apr 201811:55 amRNSHolding(s) in Company
19th Apr 20187:00 amRNSContract Award
3rd Apr 20181:03 pmRNSTotal Voting Rights
23rd Mar 20187:00 amRNSChange of auditor
20th Mar 20182:17 pmRNSResult of AGM
20th Mar 20187:00 amRNSAGM Statement
1st Mar 201811:02 amRNSTotal Voting Rights
23rd Feb 201810:35 amRNSHolding(s) in Company
15th Feb 201810:23 amRNSNotice of AGM
8th Feb 20184:27 pmRNSHolding(s) in Company
5th Feb 201812:10 pmRNSHolding(s) in Company
1st Feb 201810:51 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSContract Award
29th Jan 20185:38 pmRNSHolding(s) in Company
29th Jan 20182:30 pmRNSDirector/PDMR Shareholding
29th Jan 20182:28 pmRNSDirector/PDMR Shareholding
29th Jan 20182:25 pmRNSDirector/PDMR Shareholding
29th Jan 20182:25 pmRNSDirector/PDMR Shareholding
29th Jan 20181:47 pmRNSDirector/PDMR Shareholding
29th Jan 20181:43 pmRNSDirector/PDMR Shareholding
29th Jan 20181:38 pmRNSDirector/PDMR Shareholding
29th Jan 20181:38 pmRNSDirector/PDMR Shareholding
29th Jan 201810:46 amRNSTransaction in Own Shares
29th Jan 201810:23 amRNSTransaction in Own Shares
26th Jan 201812:32 pmRNSHolding(s) in Company
26th Jan 201812:26 pmRNSHolding(s) in Company
23rd Jan 201810:41 amRNSHolding(s) in Company
22nd Jan 201810:11 amRNSDirector/PDMR Shareholding
22nd Jan 201810:08 amRNSDirector/PDMR Shareholding
22nd Jan 201810:03 amRNSDirector/PDMR Shareholding
22nd Jan 201810:02 amRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSFULL YEAR RESULTS
3rd Jan 20189:59 amRNSBlock listing Interim Review
2nd Jan 20189:55 amRNSTotal Voting Rights
19th Dec 201710:30 amRNSHolding(s) in Company
19th Dec 201710:21 amRNSHolding(s) in Company
14th Dec 20175:09 pmRNSHolding(s) in Company
11th Dec 201711:26 amRNSHolding(s) in Company
1st Dec 20179:43 amRNSTotal Voting Rights
27th Nov 201711:05 amRNSHolding(s) in Company
14th Nov 20177:00 amRNSPOST-CLOSE STATEMENT
1st Nov 20179:05 amRNSTotal Voting Rights
30th Oct 20174:02 pmRNSHolding(s) in Company
27th Oct 20171:03 pmRNSHolding(s) in Company
27th Oct 201710:10 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.